MedTrace Logo

Attain StarFix® 4195 Lead Extraction Study

NCT00893386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2016-02-01

No results posted yet for this study

Summary

The purpose of this study is to characterize the removability of the Attain StarFix® Model 4195 Left Ventricular (LV) Lead (StarFix®). The goal of the trial is to evaluate the lead removal success in patients that are indicated for left ventricular lead removal. This study is required by the Food and Drug Administration (FDA) as a condition of approval for the Attain StarFix® Model 4195 LV Lead.

Conditions

Interventions

PROCEDURE

LV Lead Extraction

Removal of a LV lead using any tools \& techniques.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • 4195 Extraction Study Team · Medtronic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00893386 on ClinicalTrials.gov